Article info

Download PDFPDF

Original research
Effectiveness and safety of tocilizumab in patients with systemic sclerosis: a propensity score matched controlled observational study of the EUSTAR cohort

Authors

  1. Correspondence to Professor Oliver Distler; Oliver.Distler{at}usz.ch
View Full Text

Citation

Kuster S, Jordan S, Elhai M on behalf of the EUSTAR collaborators, et al
Effectiveness and safety of tocilizumab in patients with systemic sclerosis: a propensity score matched controlled observational study of the EUSTAR cohort

Publication history

  • Received May 18, 2022
  • Accepted September 14, 2022
  • First published November 3, 2022.
Online issue publication 
June 27, 2023
  • Supplementary Data

    This web only file has been produced by the BMJ Publishing Group from an electronic file supplied by the author(s) and has not been edited for content.

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.